4//SEC Filing
Siatis Perry C 4
Accession 0001415889-25-005291
CIK 0001551152other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:00 PM ET
Size
7.3 KB
Accession
0001415889-25-005291
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Siatis Perry C
EVP, GC AND SECRETARY
Transactions
- Sale
Common Stock, $0.01 par value
2025-02-20$197.40/sh−1,784$352,162→ 26,375 total - Sale
Common Stock, $0.01 par value
2025-02-20$198.12/sh−3,994$791,291→ 22,381 total
Footnotes (3)
- [F1]This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 19, 2024.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.87 to $197.7, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.88 to $198.65, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001951400
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:00 PM ET
- Size
- 7.3 KB